Tuesday, July 27, 2021 9:58:29 AM
NRx Announces Emergency Use Authorization of ZYESAMI™ (aviptadil) in Nation of Georgia
With more than one thousand new cases of the delta variant diagnosed in Georgia every day, NRx Pharmaceuticals is pleased the Prime Minister and Minister of Health of Georgia have granted Emergency Use Authorization of ZYESAMI™ for those suffering the worst of COVID-19.
Further details about this regulatory decision and the rollout of ZYESAMI™ in Georgia will be forthcoming.
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM